Error: Could not add to watchlist. X

Furiex Pharmaceuticals Inc

+ Watchlist
FURX:US
Acquired
FURX:US was acquired by AGN:US
USD
Volume
0
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-5.05
Market Cap (USD)
-
Shares Outstanding (m)
10.816
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Specialty Pharma
Profile
Furiex Pharmaceuticals, Inc. operates as a drug development company. The Company partners with pharmaceutical and biotechnology companies and provides diversified product portfolio and pipeline with multiple therapeutic candidates including late-stage assets and products in the markets. Furiex serves customers in the State of North Carolina.
ADDRESS
3900 Paramount Parkway
Suite 150
Morrisville, NC 27560
United States
PHONE
-
WEBSITE
-
  • A Robert D Bailey
    President
  • Ralph Kleinman
    Vice President
  • Rita Weinberger
    Treasurer
  • Kira Schwartz
    Secretary
Show More